Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy

Acta Oncologica

Volumn 48, Issue 4, 2009, Pages 571-577

  Ricardi, Umberto ^a   Filippi, Andrea Riccardo ^a   Guarneri, Alessia ^a   Giglioli, Francesca Romana ^b   Mantovani, Cristina ^a   Fiandra, Christian ^a   Anglesio, Silvia ^b   Ragona, Riccardo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; LUNG INJURY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SCORING SYSTEM; STEREOTACTIC BODY RADIATION THERAPY; TUMOR LOCALIZATION; CARCINOMA; COMPUTER ASSISTED RADIOTHERAPY; FOLLOW UP; HOSPITALIZATION; INCIDENCE; ITALY; LUNG; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSURGERY; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; CARCINOMA; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; LOGISTIC MODELS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 65549166927     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802520821     Document Type: Article

References (24)

1. Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, et al. High-dose radiation improved local tumour control and overall survival in patients with inoperable/ unresectable non-small cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005;/63:/324-33.
2. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumours using an accelerator; clinical experience on the first thirtyone patients. Acta Oncol 1995;/34:/861-70.
3. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flientje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A non-invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;/60:/186-96.
4. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, et al. Stereotactic hypofractionated high-dose irradiation for stage I non small cell lung carcinoma. Cancer 2004;/101:/ 1623-31.
5. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;/63:/1427-31.
6. Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;/124:/1946-55.
7. Zimmermann FB, Geinitz H, Schill S, Thamm R, Nieder C, Schratzenstaller U, et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Proceedings of the 3rd Acta Oncologica Symposium on Stereotactic Body Radiotherapy, June 15-17, 2006, Copenhagen, Denmark. Acta Oncol 2006;/45:/771-994.
8. Van den Heuvel F. Decomposition analysis of differential dose volume histograms. Med Phys 2006;/33:/297-307.
9. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to analytic function. Int J Radiat Oncol Biol Phys 1991;/21:/123-35.
10. Willner J, Jost A, Baier K, Flentje M. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3D conformal radiotherapy. Strahlenther Onkol 2003;/179:/548-559.
11. Guckenberger M, Heilman K,Wulf J, Mueller G, Beckmann G, Flentje M. Pulmonary injury and tumour response after stereotactic body radiotherapy (SBRT): Results of a serial follow-up CT study. Radiother Oncol 2007;/85:/435-42.
12. Kocak Z, Evans E, Zhou S, Miller KL, Folz RJ, Shafman TD, et al. Challenges in defining radiation pneumonitis in patients with lung cancer. Int J Radiat Oncol Biol Phys 2005;/ 62:/635-8. (Pubitemid 40779747)
13. Ohashi T, Takeda A, Shigematsu N, Kunieda E, Ishizaka A, Fukada J, et al. Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumours. Int J Radiat Oncol Biol Phys 2005;/62:/1003-8.
14. Paludan M, Traberg Hansen A, Petersen J, Grau C, Hoyer M. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency? Proceedings of the 3rd Acta Oncologica Symposium on Stereotactic Body Radiotherapy, June 15-17, 2006, Copenhagen, Denmark. Acta Oncol 2006;/45:/771-994.
15. Rodrigues G, Lock M, D'Souza D, Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer a systematic review. Radiother Oncol 2004;/71:/127-38.
16. Yorke ED, Jackson A, Rosenzsweig KE, Braban L, Leibel SA, Clifton Ling C. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2002;/54:/ 329-39.
17. Hernando ML, Marks LB, Bentel JC, Zhou SM, Hollis D, Das SK, et al. Radiation induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001;/51:/650-9.
18. Graham M, Purdy J, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;/45:/ 323-9.
19. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 2003;/67:/275-83.
20. Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC. Correlation of dosimetric factors and radiation pneumonitis for non-small cell lung cancer patients in a recently completed dose-escalation study. Int J Radiat Oncol Biol Phys 2005;/63:/672-82.
21. Armstrong J, Raben A, Zelefsky M, Burt M, Leibel S, Burman C, et al. Promising survival with three dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 1997;/44:/17-22.
22. Marks LB. Dosimetric predictors of radiation-induced lung injury. Int J Radiat Oncol Biol Phys 2002;/54:/340-7.
23. Song DY, Benedict SH, Cardinale RM, Chung TD, Chang MG, Schmidt-Ullrich RK. Stereotactic body radiation therapy of lung tumours: Preliminary experience using normal tissue complication probability-based dose limits. Am J Clin Oncol 2005;/28:/591-6.
24. Kontrisova K, Stock M, Dieckmann K, Bogner J, Potter R, Georg D. Dosimetric comparison of stereotactic body radiotherapy in different respiration conditions: A modelling study. Radiother Oncol 2006;/81:/97-104.